Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

RA Insel, JL Dunne, MA Atkinson, JL Chiang… - Diabetes …, 2015 - Am Diabetes Assoc
Insights from prospective, longitudinal studies of individuals at risk for developing type 1
diabetes have demonstrated that the disease is a continuum that progresses sequentially at …

[HTML][HTML] Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation

ES Nakayasu, M Gritsenko, PD Piehowski, Y Gao… - Nature protocols, 2021 - nature.com
Mass-spectrometry-based proteomic analysis is a powerful approach for discovering new
disease biomarkers. However, certain critical steps of study design such as cohort selection …

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience

PK Duffner, ME Horowitz, JP Krischer… - Neuro …, 1999 - academic.oup.com
The treatment of malignant brain tumors in infants and very young children: An update of the
Pediatric Oncology in Group experie Page 1 Neuro-Oncology APRIL 1999 152 The treatment …

[HTML][HTML] Temporal development of the gut microbiome in early childhood from the TEDDY study

CJ Stewart, NJ Ajami, JL O'Brien, DS Hutchinson… - Nature, 2018 - nature.com
The development of the microbiome from infancy to childhood is dependent on a range of
factors, with microbial–immune crosstalk during this time thought to be involved in the …

[HTML][HTML] Efficacy and safety of sirolimus in lymphangioleiomyomatosis

FX McCormack, Y Inoue, J Moss… - … England Journal of …, 2011 - Mass Medical Soc
Background Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in
women; it is associated with inappropriate activation of mammalian target of rapamycin …

[HTML][HTML] An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes

KC Herold, BN Bundy, SA Long… - … England Journal of …, 2019 - Mass Medical Soc
Background Type 1 diabetes is a chronic autoimmune disease that leads to destruction of
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …

[HTML][HTML] Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

PK Duffner, ME Horowitz, JP Krischer… - … England Journal of …, 1993 - Mass Medical Soc
Background Among patients with malignant brain tumors, infants and very young children
have the worst prognosis and the most severe treatment-related neurotoxic effects …

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

T Pal, J Permuth‐Wey, JA Betts… - … Journal of the …, 2005 - Wiley Online Library
BACKGROUND It is believed that BRCA1 and BRCA2 germline mutations account for the
majority of hereditary ovarian carcinomas; however, to the authors' knowledge, there are …

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

T Orban, B Bundy, DJ Becker, LA DiMeglio… - The Lancet, 2011 - thelancet.com
Background The immunopathogenesis of type 1 diabetes mellitus is associated with T-cell
autoimmunity. To be fully active, immune T cells need a co-stimulatory signal in addition to …

[HTML][HTML] The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

T Vatanen, EA Franzosa, R Schwager, S Tripathi… - Nature, 2018 - nature.com
Abstract Type 1 diabetes (T1D) is an autoimmune disease that targets pancreatic islet beta
cells and incorporates genetic and environmental factors, including complex genetic …